Glycemic control and excess mortality in type 1 diabetes

New England Journal of Medicine

Volumn 371, Issue 21, 2014, Pages 1972-1982

  Lind, Marcus ^a,b   Svensson, Ann Marie ^c   Kosiborod, Mikhail ^g,h   Gudbjörnsdottir, Soffia ^b   Pivodic, Aldina ^d   Wedel, Hans ^e   Dahlqvist, Sofia ^a   Clements, Mark ^h,i,j   Rosengren, Annika ^b,f  

^a NU Hospital Organization   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Center of Registers in Region Vastra Götaland   (Sweden)

^d Statistiska Konsultgruppen   (Sweden)

^e NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^h UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

ⁱ CHILDREN S MERCY HOSPITAL   (United States)

^j UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; RENIN INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE REGISTRY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OBSERVATIONAL STUDY; RISK ASSESSMENT; SEX RATIO; SWEDEN; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; REGISTER; RISK;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RISK; SWEDEN;

EID: 84911375963     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1408214     Document Type: Article

References (33)

1. Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med 2012;9(10):e1001321.
2. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care 2006;29:2528-38.
3. Secrest AM, Becker DJ, Kelsey SF, LaPorte RE, Orchard TJ. All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County type 1 diabetes registry. Diabetes Care 2010;33:2573-9.
4. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia 2006;49:660-6.
5. Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 2003;46:760-5.
6. Harjutsalo V, Forsblom C, Groop PH. Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ 2011;343:d5364.
7. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16:459-65.
8. Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 2006;49:298-305.
9. Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes 2010;59:3216-22.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
11. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
12. American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care 2014;37:Suppl 1:S14-S80.
13. Cheng AY. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: introduction. Can J Diabetes 2013;37:Suppl 1:S1-S3.
14. National Institute for Health and Care Excellence. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults (http://egap.evidence.nhs.uk/type-1-diabetescg15/guidance#blood-glucose-control-and-insulin-therapy).
15. National Board of Health and Welfare Sweden, 2010 (http://www.socialstyrelsen.se/nationellariktlinjerfordiabetesvarden).
16. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004;21:657-65.
17. Swedish National Diabetes Register. Annual Report 2012 (https://www.ndr.nu/pdf/Annual-Report-NDR-2012.pdf).
18. Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 2011;378:140-6.
19. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care 2010;33:1640-6.
20. Olén O, Bihagen E, Rasmussen F, Ludvigsson JF. Socioeconomic position and education in patients with coeliac disease. Dig Liver Dis 2012;44:471-6.
21. Emilsson L, Smith JG, West J, Melander O, Ludvigsson JF. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 2011;32:2430-7.
22. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register - opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726-35.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-70.
24. Lind M, Odén A, Fahlén M, Eliasson B. A systematic review of glycated hemoglobin variables used in the study of diabetic complications. Diab Met Syndr Clin Res Rev 2008;2:282-93.
25. Shankar A, Klein R, Klein BE, Moss SE. Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes. Am J Epidemiol 2007;166:393-402.
26. Groop P-H, Thomas MC, Moran JL, et al. The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 2009;58:1651-8.
27. Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008;31:1360-6.
28. Weis U, Turner B, Gibney J, et al. Long-term predictors of coronary artery disease and mortality in type 1 diabetes. QJM 2001;94:623-30.
29. Lind M, Odén A, Fahlén M, Eliasson B. The true value of glycated hemoglobin as a predictor of diabetic complications: simulations of glycated hemoglobin variables. PLoS One 2009;4(2):e4412.
30. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 2013;56:2601-8.
31. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2010;53:2312-9.
32. Parving HH, Mauer M, Ritz E. Diabetic nephropathy. In: Brenner BM, ed. Brenner and Rector's the kidney, 7th ed. Philadelphia: WB Saunders, 2004:1777-818.
33. Hana˚s R. Type 1 diabetes in children, adolescents and young adults - how to become an expert on your diabetes. 4th ed. London: Class Publishing, 2008.